Nektar Therapeutics
Trade Nektar Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NKTR
Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit.
NKTR Key Statistics
Stock Snapshot
As of today, Nektar Therapeutics(NKTR) shares are valued at $70.73. The company's market cap stands at 2.43B, with a P/E ratio of -8.40.
On 2026-07-25, Nektar Therapeutics(NKTR) stock moved within a range of $69.60 to $74.70. With shares now at $70.73, the stock is trading +1.6% above its intraday low and -5.3% below the session's peak.
Trading volume for Nektar Therapeutics(NKTR) stock has reached 835.87K, versus its average volume of 732.77K.
The stock's 52-week range extends from a low of $21.02 to a high of $109.00.
The stock's 52-week range extends from a low of $21.02 to a high of $109.00.
NKTR News
...
Nektar Therapeutics has produced very strong share price gains over the last three years, yet on Simply Wall St’s broader checks it screens as expensive rather...
Analyst ratings
91%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.